Prescribed Drugs Provider Manual - Iowa Department of Human ...
Prescribed Drugs Provider Manual - Iowa Department of Human ...
Prescribed Drugs Provider Manual - Iowa Department of Human ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Iowa</strong><strong>Department</strong><strong>of</strong> <strong>Human</strong>Services<strong>Provider</strong> and Chapter<strong>Prescribed</strong> <strong>Drugs</strong>Chapter III. <strong>Provider</strong>-Specific PoliciesPage29DateAugust 1, 2013♦ Granisetron/Kytril ® :• Eight 1 mg tablets• 30 ml oral solution (1 mg/5 ml)• Eight vials (1 mg/ml)• Two vials (4 mg/ml)♦ Ondansetron ODT/Z<strong>of</strong>ran ODT ® :• Twelve 4 mg tablets• Twelve 8 mg tablets♦ Ondansetron/Z<strong>of</strong>ran ® :• Twelve 4 mg tablets• Twelve 8 mg tablets• Four 24 mg tablets• 50 ml/month oral solution (4 mg/5 ml)• Four 20 ml vials (2 mg/ml)• Eight 2 ml vials (2 mg/ml)♦ Palonosetron/Aloxi ® : Four vials (0.25 mg/ml)Payment for antiemetic-5HT3 receptor antagonists/substance P neurokininagents beyond these limits will be considered on an individual basis afterreview <strong>of</strong> submitted documentation.NOTE: Aprepitant (Emend ® ) is payable only when used in combination withother antiemetic agents (5-HT3 medication and dexamethasone) for patientsreceiving highly emetogenic cancer chemotherapy.Prior authorization is required for all nonpreferred antiemetic-5HT3 receptorantagonists/substance P neurokinin medications beginning the first day <strong>of</strong>therapy.Payment for nonpreferred medications will be authorized only for cases inwhich there is documentation <strong>of</strong> previous trials and therapy failure with apreferred agent in this class.Use form 470-4410, Request for Prior Authorization: Antiemetic-5HT3Receptor Antagonists/Substance P Neurokinin Products, to request priorauthorization. Click here to see a sample <strong>of</strong> the form.